Biostage Stock Z Score
BSTGDelisted Stock | USD 4.20 0.09 2.10% |
Biostage |
Biostage OTC Stock Z Score Analysis
Biostage's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionIn accordance with the company's disclosures, Biostage has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Biostage Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biostage's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Biostage could also be used in its relative valuation, which is a method of valuing Biostage by comparing valuation metrics of similar companies.Biostage is currently under evaluation in z score category among its peers.
Biostage Fundamentals
Return On Equity | -4.92 | |||
Return On Asset | -2.11 | |||
Current Valuation | 78.64 M | |||
Shares Outstanding | 11.64 M | |||
Shares Owned By Insiders | 50.95 % | |||
Number Of Shares Shorted | 121.66 K | |||
Price To Earning | (0.16) X | |||
Price To Book | 28.47 X | |||
EBITDA | (8.36 M) | |||
Net Income | (7.98 M) | |||
Cash And Equivalents | 4.64 M | |||
Cash Per Share | 0.40 X | |||
Total Debt | 115 K | |||
Debt To Equity | 0.04 % | |||
Current Ratio | 2.26 X | |||
Book Value Per Share | (0.16) X | |||
Cash Flow From Operations | (2.63 M) | |||
Short Ratio | 3.35 X | |||
Earnings Per Share | (0.89) X | |||
Target Price | 3.0 | |||
Beta | -0.91 | |||
Market Capitalization | 73.82 M | |||
Total Asset | 1.87 M | |||
Retained Earnings | (65.78 M) | |||
Working Capital | 7.23 M | |||
Current Asset | 7.88 M | |||
Current Liabilities | 654 K | |||
Net Asset | 1.87 M |
About Biostage Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biostage's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biostage using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biostage based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Biostage OTC Stock
If you are still planning to invest in Biostage check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostage's history and understand the potential risks before investing.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |